Escolar Documentos
Profissional Documentos
Cultura Documentos
Nycomed Australia
section name
OUR VALUES
Courage
Empathy
Trust
Motivation
Contents
Welcome 2
Nycomed at a glance 3
Willem Dekker
Managing Director
It is with great pleasure that I introduce you a trusted position in the minds of patients
to Nycomed Australia through our Pioneering and prescribers. In the self-medication arena,
Partnerships company brochure. Pioneering Nycomed is poised to introduce an innovative
Partnerships has been created to provide you range of premium over-the-counter
with valuable insights into the culture and pharmacy-only brands.
business focus that make Nycomed a preferred To grow our business, we will need to sustain
partner in our fields of endeavour. our current value, expand and diversify.
Australia seems to attract the pioneering spirit; A cornerstone of this success strategy is our
from the arrival of the Aboriginal people around ability to continue to develop and successfully
50,000 years ago to the European settlements market our existing products. The ongoing
of the past 200 years. Nycomed understands marketing momentum of our current product
this strength and has translated it to drive our portfolio will continue through operational
success in the Australian pharmaceutical market. excellence and skillful lifecycle management.
Established in Australia in 2001 as ALTANA To expand and diversify we will leverage our
Pharma and becoming Nycomed in 2007, we proven success as a trusted business partner to
have always recognised that the pioneering spir- form alliances with pharmaceutical companies
it is not a concept limited to the early phases of that create shared value for patients, healthcare
providers and our partners.
“To sustain our an organisation’s life, but a business approach in
itself. It requires a continuous commitment to We believe that everything we do matters to
business, we will maintain a responsive, reliable, flexible, diverse somebody. No matter where we work, each of
need to defend our and results-focused organisation. This approach us contributes to making a better quality of life
has allowed Nycomed Australia to develop for patients.
current value, a profile as a dynamic partnership-focused In this brochure, the Nycomed Leadership
expand & diversify” organisation with the ability to introduce Team introduces you to the many facets of our
products that make a real difference to patients, business. Read on and you will discover more
healthcare providers and our business partners. about how our partnerships positively contribute
As one of Australia’s top 30 pharmaceutical to the life of Australians.
companies, our focus extends to three core
healthcare business pillars. These are: Warm regards,
primary care prescription medication
hospital specialty medication and
self-medication. Willem Dekker
In primary care and hospital settings our Regional Director—Australia and New Zealand
products Somac® (pantoprazole, for the
treatment of acid-related gastrointestinal
Willem Dekker can be contacted at
disease) and Alvesco® (ciclesonide, for the Willem.Dekker@nycomed.com
treatment of chronic asthma) have earned
NYCOMED AT A GLANCE
Welcome
Nycomed is a privately owned pharmaceutical company that OUR MISSION
provides medicines for hospitals, specialists and general practitioners, Our mission is to bring medicines that matter
as well as over-the-counter medicines in selected markets.
to patients and healthcare providers.
The company is active in a range of therapeutic areas. Its key products are
aimed at gastroenterology, pain management, osteoporosis, respiratory
diseases and tissue management. OUR VISION
New products are sourced both from our own research and from business Our vision is to become the preferred
partners. Partnerships in all parts of the value chain play an essential role in pharmaceutical company by being responsive,
Nycomed’s business strategy. reliable and focusing on results.
100
90 2,000
80
1,500
70
1,000
60
50 500
140 12,000
120
100 9,000
80
60 6,000
40
20 3,000
PRODUCT THERAPEUTIC AREA SALES 2007 UNIT GROWTH PRODUCT THERAPEUTIC AREA SALES 2007 UNIT GROWTH
Source IMS
Partners in Practice
Section 1
Gary Bower
Sales & Marketing Director: Pharma
Building valued partnerships with the medical Australia and New Zealand. Nycomed is also
professionals who prescribe and recommend our excited by the prospect of pioneering new
products is both Nycomed’s greatest challenge relationships with peak bodies in our
and our greatest reward. These aspirations as emerging areas of therapeutic interest.
well as our commitment to provide medicines As a member of Medicines Australia,
that offer real promise to patients, drives us to Nycomed is devoted to strengthening the
seek innovative and efficient ways of presenting pharmaceutical industry’s position as a partner
our products to the Australian market. in quality healthcare delivery. This is achieved
For our medicines to be considered as the first through the ethical promotion of our products
option within their therapeutic area, Nycomed and our support of the Medicines Australia
understands that we must first earn this place Code of Conduct. Nycomed and its people
in the minds of those who prescribe and are proud of their contribution to the
recommend our medicines. Australian healthcare environment and seek
Through our commitment to the ethical to ensure
and professional delivery of quality medical that our organisation acts as a trusted phar-
education, Nycomed is continually building maceutical partner.
valued relationships with the medical Our commitment to providing quality medicines
“Building valued community. This is achieved by the creation of also encompasses our focus on delivering treat-
focused disease state education programs, and ments that are considered cost effective
partnerships with the the facilitation of knowledge sharing between by government and private funders. By offering
medical professionals thought leaders and primary care practitioners. value for money we ensure that our products are
While we always strive to keep Somac® widely available to the Australian community.
who prescribe and (pantoprazole) and Alvesco® (ciclesonide) at Every day across Australia, our highly trained
recommend our the “top of the mind” of Australian prescribers, industry-accredited representatives bring life
our activities are often unrelated to our to our products and services. They are the
products is both products and instead focus on topics of clearly face of Nycomed. Our professional team
Nycomed’s greatest identified educational needs within the areas of is committed to our vision to become the
Gastroenterology and Respiratory Medicine. preferred pharmaceutical company by being
challenge and our In addition to building relationships with responsive, reliable and by understanding cus-
greatest reward.” individual healthcare professionals, Nycomed tomer needs. We look forward to building
seeks to develop productive partnerships with a trusted partnership with you and positively
the peak bodies that share our therapeutic contributing to the health of Australians.
focus. For example, The Gastroenterological
Society of Australia guides us in the field of
gastroenterology. In the area of respiratory Gary Bower is your prescription medicines
medicine, our organisation has developed commercial partner at Nycomed.
positive relationships with both the National Gary can be contacted at Gary.Bower@nycomed.com
Asthma Council and the Thoracic Society of
Section 2: Partners in Practice
Jennifer Connolly
Regulatory Affairs Manager
The Nycomed Scientific Affairs Department is a The expertise of our department is broad and
focal point for the introduction of our extensive encompasses more than prescription
pipeline of innovative new medicines. As an medications. Scientific Affairs plays an important
integral part of Nycomed’s global research role in making Nycomed’s innovative products
and development network, we ensure that more widely available to Australians as they
new discoveries generated from our in-house transition from prescription to over-the-counter
discovery programmes and from our partnerships use. Also, we are actively involved in supporting
with biotechs, academia and pharmaceutical Nycomed’s emerging consumer health business
companies are made available to Australians. through the registration of new pharmacy-only
Our role starts early in the life of our products. non-prescription medicines.
As an active partner in Nycomed’s global Through our valued scientific, medical and
clinical trials program Nycomed Australia has business partnerships the Nycomed Scientific
undertaken clinical trials involving over 50 Affairs Department contributes to all phases the
Australian trial sites and hundreds of patients product lifecycle and we look forward to bringing
across Australia. Our commitment to local you new medicines that offer real promise for
clinical partnerships is strong and we are proud Australian patients.
that Australian researchers have contributed
significantly to the body of scientific evidence
“We look forward to supporting Somac® (pantoprazole), Alvesco® Jennifer Connolly is your scientific affairs partner at Nycomed.
bringing you new (ciclesonide) and Daxas® (roflumilast). Jennifer can be contacted at Jennifer.Connolly@nycomed.com
medicines that offer Making new medicines available to Australians
extends beyond our quality clinical research.
real promise for The Scientific Affairs Department ensures that
Australian patients.” Nycomed products meet the highest regulatory
standards. Our involvement begins at the initial
regulatory submission and continues throughout
a product’s lifecycle as we support our marketing
teams in attaining the highest standards of ethi-
cal marketing and promotion demanded by our
industry’s Code of Coduct.
The Scientific Affairs Department also provides
a comprehensive range of medical services,
product information and safety monitoring to
ensure that all our products are supported to the
highest standards.
Partners in Pharmacy
Section 2
Peter Dydusiak
Sales and Marketing Director: Consumer Healthcare
Section 2: Partners in Pharmacy
Top 10 Australian OTC Categories
Millions $A (MAT Mar 08)
400
350
379
300
250
200
222
198
184
150
144
100
99
50
80
74
66
54
& gy ics al al
s as n m ls ns
ld y lo s
st
in er ul tio te ica tio
co lerg to lge e in m sa ys og ra
,
h l a na nt m or ce
s ls ol pa
ug l a rm a ro
i tf ta m re
co asa de st s& n in
g le al
ga in in
fa
ok sk
e th gp
n m h in
ita sm l o- op m
v cu sli
m
us
m
Nycomed Expertise
Source IMS API - March 2008
Partners in Delivery
Section 3
Rob Hanna
Finance and Human Resources Director
Section 3: Partners in Delivery
99.99%
99.98%
75%
50%
25%
% Despatched on-time
Partners in
Business Development
Section 4
Cathy Harvey
Business Development Manager
Central to Nycomed’s success is our ability Nycomed aims to partner with companies
to form strong and enduring partnerships. seeking collaborations in the following areas:
Our alliances with some of Australia’s largest Product or portfolio divestment
pharmaceutical companies has proven our Out-licensing
ability to create shared value in primary care Co-promotion and co-marketing
and specialty markets. Joint ventures
We aim to drive our future success through the Outsourced management of non-strategic
development of an impressive and balanced or under-promoted brands
product portfolio. This will be achieved by a In-licensing of selected Nycomed products
series of collaborations and acquisitions that We are also actively seeking growth
leverage our research, development, regulatory, opportunities through the acquisition of
marketing and sales expertise. Our business companies in the prescription and over-the
development team will manage all collaborative counter market segments.
opportunities in a rapid and responsible If proven partnership credentials are essential
manner. The flexible and creative approach to to your future success, make Nycomed your
collaborations allows us to consider a range of preferred partner.
business development models with the aim
of creating a mutually beneficial outcome for
“Our alliances with Nycomed and our potential partners.
Cathy Harvey is your business development partner
some of Australia’s The Nycomed Business Development at Nycomed.
largest pharmaceutical Team would like to hear from organisations Cathy can be contacted at Cathy.Harvey@nycomed.com
with products or projects at all stages of
companies has proven development. Our company offers extensive
our ability to create expertise and infrastructure across the
Australian, New Zealand and Asia Pacific
shared value in markets to maximise the potential of our
primary care and business alliances.
specialty markets.”
10
Section 4: Partners in Business Development
Nycomed’s
Partnership Credentials
Infrastructure
Fully formed pharmaceutical organisation with primary care, specialty and
consumer health expertise
Sales
Sales organisation comprising over 70 primary care and specialist areas
Sales professionals who exceed industry benchmarks for sales force efficiency
Marketing
Proven ability to launch and manage high value primary care prescription
brands in competitive markets
Proven ability to launch complex specialty products in niche markets.
Regulatory
Capacity to generate, submit and maintain regulatory documentation to
Therapeutic Goods Administration standards
Reimbursement
Demonstrated reimbursement success in demanding health-outcome
driven environments
Logistics
Ability to efficiently deliver pharmaceuticals to diverse customers
across Australia.
Partnership Culture
Experience in alliance management
Flexible and creative approach to collaborations
Objective and rapid response to partnering opportunities
Results driven culture
Partnership Focus
Focused existing product portfolio allows for significant attention to
partner products
High level of regard and value for partners
11
Pioneering a new career
Section 5
Recognition
Nycomed Australia has created an environment that celebrates success and
recognises the contribution of individuals to our shared goals. As a medium
sized pharmaceutical company Nycomed offers team members the opportunity
to be more readily recognised for their achievements.
Reward
Nycomed seeks to be an employer of choice by offering highly competitive
packages and employment conditions. We also recognise not all rewards are
tangible and we believe our values of Courage, Empathy, Trust and Motivation
create a culture in which our employees thrive.
Development
Our people create our success and we are committed to partnering with
our employees to help them achieve their short and long term career goals.
We encourage all employees to reach their full potential through active
participation in our career development processes.
If you would like to apply for a role at Nycomed Pty Ltd, we encourage you to
visit the Careers section of our website (www.nycomed.com.au) or contact our
Human Resources Department via email at au-recruitment@nycomed.com.
12
> Our Values
Empathy
Listening
Showing respect
Showing commitment
Showing intercultural understanding
Trust
Being loyal
Keeping agreements
Being honest and sincere
Having continuous communication
Motivation
Encouraging enthusiasm, creativity and innovation
Optimising energy, for groups and individuals
Giving adequate support and challenge
Empowering your people
13
Partnering for future success
Section 6
Strong and trustworthy Nycomed will unlock the full potential of our products for the
benefit of patients by actively seeking line extensions and new
with impressive organic through our collaborations with trusted business partners in the
fields of gastroenterology, respiratory medicine, pain management
growth will define and over-the-counter care. Our R&D investment and collaborative
partnerships will allow us to develop a risk profile that supports a
Nycomed Australia’s
balanced participation in the reimbursed and non-reimbursed
sectors of the Australian pharmaceutical market.
15
Willem Dekker
Managing Director
Willem.Dekker@nycomed.com
Gary Bower
Sales & Marketing Director: Pharma
Gary.Bower@nycomed.com
Jennifer Connolly
Regulatory Affairs Manager
Jennifer.Connolly@nycomed.com
Peter Dydusiak
Sales and Marketing Director: Consumer Healthcare
Peter.Dydusiak@nycomed.com
Rob Hanna
Finance and Human Resources Director
Rob.Hanna@nycomed.com
Cathy Harvey
Business Development Manager
Cathy.Harvey@nycomed.com
16
Publisher
Nycomed Pty Ltd
Concept design and copywriting
Antidote Marketing
17
Pioneerin
partner
18